Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy.

Abstract

Genes, infection, malnutrition, and other factors affecting fetal brain development are a major component of risk for a child's emotional development and later mental illnesses, including schizophrenia, bipolar disorder, and autism. Prenatal interventions to ameliorate that risk have yet to be established for clinical use. A systematic review of prenatal nutrients and childhood emotional development and later mental illness was performed. Randomized trials of folic acid, phosphatidylcholine, and omega-3 fatty acid supplements assess effects of doses beyond those adequate to remedy deficiencies to promote normal fetal development despite genetic and environmental risks. Folic acid to prevent neural tube defects is an example. Vitamins A and D are currently recommended at maximum levels, but women's incomplete compliance permits observational studies of their effects. Folic acid and phosphatidylcholine supplements have shown evidence for improving childhood emotional development associated with later mental illnesses. Vitamins A and D decreased the risk for schizophrenia and autism in retrospective observations. Omega-3 fatty acid supplementation during early pregnancy increased the risk for schizophrenia and increased symptoms of attention deficit hyperactivity disorder, but in later pregnancy it decreased childhood wheezing and premature birth. Studies are complicated by the length of time between birth and the emergence of mental illnesses like schizophrenia, compared with anomalies like facial clefts identified at birth. As part of comprehensive maternal and fetal care, prenatal nutrient interventions should be further considered as uniquely effective first steps in decreasing risk for future psychiatric and other illnesses in newborn children. [AJP at 175: Remembering Our Past As We Envision Our Future July 1959: Longitudinal Observations of Biological Deviations in a Schizophrenic Infant Barbara Fish described the course of an infant born with fluctuating motor problems who developed schizophrenia. (Am J Psychiatry 1959; 116:25-31 )].

• Authors: Robert Freedman, Sharon K Hunter, M Camille Hoffman
• Journal: The American journal of psychiatry (Am J Psychiatry) Vol. 175 Issue 7 Pg. 607-619 (07 01 2018) ISSN: 1535-7228 [Electronic] United States
• PMID: 29558816 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Systematic Review)

Chemical References

• Fatty Acids, Omega-3
• Micronutrients
• Phosphatidylcholines
• Folic Acid

Topics

• Dietary Supplements
• Fatty Acids, Omega-3 (therapeutic use)
• Female
• Folic Acid (therapeutic use)
• Humans
• Mental Disorders (prevention & control)
• Micronutrients (administration & dosage, therapeutic use)
• Phosphatidylcholines (therapeutic use)
• Pregnancy
• Prenatal Care (methods)
• Primary Prevention (methods)